We are thrilled to announce that EssilorLuxottica has acquired our portfolio company Ikerian (operating under the RetinAI brand). This exit marks a major milestone for the Swiss and European deep-tech ecosystem.

founders ikerian
Carlos Ciller, Stefanos Apostolopoulos, Sandro De Zanet
Co-founders, Ikerian (Retinai)

Dr. Carlos Ciller co-founded RetinAI (later Ikerian AG) in 2017 with Dr. Stefanos Apostolopoulos and Dr. Sandro De Zanet, assembling a team of PhD-level experts from leading research institutions including the University of Bern, EPFL, and the University of Lausanne. The company, which was recently acquired by EssilorLuxottica is recognized for its certified RetinAI Discovery® platform, an AI-powered solution that manages and analyzes large-scale medical imaging data to accelerate clinical and pharmaceutical workflows in eye care.

Written by

Investors

Verve Event Zurich Investors

Our sophisticated investors include visionary family offices, leading wealth managers, institutions, founders, and senior executives. These individuals and organizations are all committed to shaping the next generation of innovation.

Learn more

Privacy Preference Center